Tower Research Capital (TRC)’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Tower Research Capital (TRC)’s Portfolio NPSP Stock Details NPSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-216	Closed	-$8K	–	5490
2014 Q4	$8K	Sell	216 -3,024	-93%	-$90.3K	﹤0.01%	2399
2014 Q3	$84K	Buy	+3,240	New	+$93.1K	0.01%	1116
2014 Q2	–	Sell	-134	Closed	-$4K	–	5236
2014 Q1	$4K	Buy	+134	New	+$4.62K	﹤0.01%	3535
2013 Q4	–	Sell	-6,023	Closed	-$191K	–	5326
2013 Q3	$191K	Buy	6,023 +3,042	+102%	+$69.8K	0.02%	785
2013 Q2	$45K	Buy	+2,981	New	+$41.3K	﹤0.01%	1033

Other funds holding NPSP

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Tower Research Capital (TRC)'s NPSP Position: Q1 2015 in Review

Tower Research Capital (TRC) sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 216 shares — an estimated $8K sold.

Tower Research Capital (TRC) first reported a position in NPSP in Q2 2013 and held it in 5 quarters. The position peaked at $191K in Q3 2013. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

Tower Research Capital (TRC) reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Tower Research Capital (TRC) sold 216 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $8K.
Tower Research Capital (TRC) first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
Tower Research Capital (TRC)'s NPS PHARMACEUTICALS INC position peaked at $191K in Q3 2013.
1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2015, filed 12 May 2015.